Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06916247 · ClinicalTrials.gov registry record · NA
Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program
A NA study of Chronic Disease, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 5,000
- Enrollment target
- 1
- Study location
NCT06916247: Recruiting NA study of Chronic Disease, sponsored by University of California, Los Angeles.
NCT06916247 is a NA study of Chronic Disease that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 5,000 participants, below the 89,839-participant average among 48 other Chronic Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06916247, a NA study of Chronic Disease, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Currently, UCLA Health (specifically the Office of Population Health and Accountable Care, or OPHAC) runs a complex care management program called Proactive Care (goal is to reduce care utilization by providing personalized care navigation/case management). Every month, an AI Population Risk tool runs to identify around 250 of the 480,000 or so UCLA primary care patients, and RNs contact these 250 patients to enroll in Proactive Care. Starting in December 2024, OPHAC launched a new method of enrolling UCLA's Medicare Advantage (MA) patients into Proactive Care: an AI Cost Prediction model. The idea is the same-- the top 250 highest predicted cost patients will be enrolled in Proactive Care. The investigators will evaluate this model and subsequent enrollment into the program by randomizing the waitlist of MA patients waiting to enroll in Proactive Care, thereby creating a control group. The top 500 highest predicted cost patients will be identified each month, and following a 1:1 randomization, 250 will be contacted for enrollment and the rest will be put on a wait-list control group for 10 months unless otherwise requested by their provider to be enrolled in the Proactive Care program earlier.
Primary Outcome
The sum of the number of days that a patient is not hospitalized under inpatient or observation status, and alive, out of a maximum of 120 days post-randomization.
Conditions Studied
Interventions
- BEHAVIORAL Complex care management program
Study Locations (1)
California
- UCLA Health - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2024-08-16 |
| Est. Completion | 2026-05-12 |
| Phase | NA |
What NCT06916247 shows while recruiting
NCT06916247 is an interventional study that assigns participants to a tested intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, below the 89,839-participant average among 48 other Chronic Disease trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which Complex care management program is the first listed.
NCT06916247 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06916247 about?
NCT06916247 is a clinical study titled "Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program". Currently, UCLA Health (specifically the Office of Population Health and Accountable Care, or OPHAC) runs a complex care management program called Proactive Care (goal is to reduce care utilization by providing personalized care navigation/case management). Every month, an AI Population Risk tool ru...
What is the current status of trial NCT06916247?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,000 participants. The study started on 2024-08-16. Estimated completion is 2026-05-12.
What conditions does trial NCT06916247 study?
This clinical trial studies the following conditions: Chronic Disease.
What interventions are being tested in trial NCT06916247?
The interventions under investigation include: Complex care management program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06916247?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06916247 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06916247's enrollment target sits among peer trials
5,000 9th of 48 higher than 40 of 48 other Chronic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Click & Pick Study
RECRUITING · NA
-
Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors
RECRUITING · NA
-
Comparative Effectiveness of IIMR Versus CDSMP
RECRUITING · NA
-
Training Community Members to be Coaches to Deliver the HealthyLifetime Program
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Families Implementing Good Health Traditions for Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI